Imerys (NK) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Revenue for the first nine months of 2024 reached €2,773 million, with Q3 revenue at €855 million, reflecting solid volume recovery and stable pricing year-over-year, driven by specialty minerals and market share gains.
Adjusted EBITDA for the first nine months was €533 million (+3% year-over-year), with a margin of 19.2% (+140 bps), supported by cost reductions, operating leverage, and joint venture contributions.
Current net income (group share) for nine months at €214 million, up 11.3% year-over-year.
Net income, group share, was -€143 million for the first nine months, impacted by a non-cash translation reserve loss from the disposal of paper market assets.
Full-year 2024 adjusted EBITDA guidance is confirmed at €670–690 million, reflecting confidence in operational resilience.
Financial highlights
Q3 2024 organic revenue growth was 4.1% year-over-year, with volumes up 3.8% and prices up 0.3%.
Year-to-date organic revenue growth was 0.1%, with volumes up 0.9% and prices down 0.8%.
Adjusted EBITDA for Q3 was €148 million; nine-month adjusted EBITDA at €533 million, with a 19.2% margin (up 140–150 bps year-over-year).
Current operating income for nine months at €330 million (11.9% of sales), up 9.8% year-over-year.
Net income, group share, for nine months was -€143 million, mainly due to a non-cash translation reserve loss.
Outlook and guidance
Full-year 2024 adjusted EBITDA guidance maintained at €670–690 million, reflecting confidence in resilience and a diversified portfolio.
Management remains prudent due to macroeconomic and geopolitical uncertainties but expects continued outperformance and volume-driven growth.
Construction and residential markets expected to recover as interest rates fall, providing further growth potential.
Latest events from Imerys
- Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 202520 Feb 2026 - Strong 2024 results, higher dividend, strategic progress, and all resolutions approved.NK
AGM 20253 Feb 2026 - H1 2024 adjusted EBITDA rose 11% to €384m, margin 20%, with strong cash flow and guidance.NK
H1 20242 Feb 2026 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 202524 Dec 2025 - Organic growth, margin expansion, and strong ESG progress with robust 2025 outlook.NK
H2 202415 Dec 2025 - Stable H1 2025 sales and EBITDA, but net income fell; full-year EBITDA guidance reaffirmed.NK
Q2 202516 Nov 2025 - Revenue down 0.7% YTD; cost controls and strategic growth moves support profitability.NK
Q3 20251 Nov 2025